comparemela.com

Page 7 - Korro Bio Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Analysts Offer Predictions for Korro Bio, Inc s FY2023 Earnings (NASDAQ:KRRO)

Analysts Offer Predictions for Korro Bio, Inc s FY2023 Earnings (NASDAQ:KRRO)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesDavidl lucchinoPiper sandlerKorro bioKorro bio incRoyal bankSecurities exchange commissionExchange commissionAtlas venture life science advisorsFree reportVenture life science advisorsDirector davidGet free reportKorro bio daily

Private equity firms are Korro Bio, Inc s (NASDAQ:KRRO) biggest owners and were rewarded after market cap rose by US$161m last week

Key Insights The considerable ownership by private equity firms in Korro Bio indicates that they collectively have a.

Korro bioKorro bio incPrivate equity firmsKorro bioNstitutional ownershipBusiness strategyPrivate equityNsider ownership

Inhibrx, Sanofi ratify $2 2B deal for AATD therapy

Inhibrx Inc. and Sanofi SA have agreed to a deal worth up to $2.2 billion, whereby the latter’s Aventis Inc. subsidiary will acquire INBRX-101, an optimized, recombinant alpha-1 antitrypsin (AAT) augmentation therapy undergoing a registrational trial for AAT deficiency (AATD), an inherited genetic disorder caused by single nucleotide variants in the SERPINA1 gene.

Aventis incInhibrx incInhibrx incSanofi saInbrx 101Aventis incAlpha 1 antitrypsin deficiencyDeals andm amp aAat deficiencyKorro bio incBeam therapeutics incMereo biopharma group plc

Korro Bio (NASDAQ:KRRO) Given Buy Rating at HC Wainwright

HC Wainwright restated their buy rating on shares of Korro Bio (NASDAQ:KRRO – Free Report) in a report published on Friday, Benzinga reports. The brokerage currently has a $100.00 price objective on the stock. A number of other brokerages also recently issued reports on KRRO. Royal Bank of Canada assumed coverage on Korro Bio in […]

United kingdomUnited statesKorro bioDavidl lucchinoPiper sandlerStar investment management corpRoyal bankKorro bio incSecurities exchange commissionFree reportDirector davidExchange commissionStar investment managementGet free reportKorro bio dailyNasdaq krro

Korro Bio Highlights Data for its Lead Program in Alpha-1 Antitrypsin Deficiency (AATD) and Progress Across its RNA Editing Portfolio

Korro Bio Highlights Data for its Lead Program in Alpha-1 Antitrypsin Deficiency (AATD) and Progress Across its RNA Editing Portfolio
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomRam aiyarKorro bio incProgram in alphaBio highlights dataLead programProgress acrossHealthcare conferenceChief executive officerAlter proteinCurrent reportContact information

vimarsana © 2020. All Rights Reserved.